Literature DB >> 18419256

Identification of human CD4 T-cell epitopes on the VP1 capsid protein of enterovirus 71.

Damian Guang Wei Foo1, Paul A Macary, Sylvie Alonso, Chit Laa Poh.   

Abstract

The identification of human CD4 T-cell epitopes within a protein vaccine candidate is of great interest,as it provides a better understanding of the mechanisms involved in protective immunity and may therefore help in the design of effective vaccines and diagnostic tools. The entire amino acid sequence of the VP1 capsid protein from enterovirus 71 (EV 71) strain 41 was submitted to analysis by the ProPred algorithm for the identification of potential promiscuous human CD4 T-cellepitopes. Three regions spanning amino acids 66-77, 145-159, and 247-261 of VP1 were predicted to bind more than 25 HLA-DR alleles. The corresponding synthetic peptides (SP1 to SP3) were then tested for their abilities to induce proliferation of CD4 T cells isolated from five human volunteers screened positive for previous EV 71 exposure and one EV 71-negative volunteer. Upon stimulation with either peptide, CD4 T-cell proliferative responses were observed for all EV 71-positive volunteers,indicating the presence of EV 71-specific memory CD4 T cells. The amplitude of the proliferative responses was peptide- and HLA-DR-dependent, and correlated well with the ProPredpredicted binding efficiencies. Moreover, CD4 T cells from EV 71-positive volunteers produced significant levels of IL-2 and IFN- upon stimulation, indicative of a T-cell differentiation into Th-1-type subset. Among the three peptides, SP2 induced the highest proliferative response and cytokine production. Moreover, SP2-induced proliferative response could be inhibited with anti-major histocompatibility complex (MHC) class II antibody, indicating that SP2 represents a MHC class II-restricted CD4 T-cell epitope. This study demonstrates that the ProPred algorithm can accurately predict the presence of human CD4 T-cell epitopes within the VP1 capsid protein of EV 71, and therefore represents a useful tool for the design of subunit vaccines against EV 71.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18419256     DOI: 10.1089/vim.2007.0089

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  13 in total

1.  The utility and limitations of current Web-available algorithms to predict peptides recognized by CD4 T cells in response to pathogen infection.

Authors:  Francisco A Chaves; Alvin H Lee; Jennifer L Nayak; Katherine A Richards; Andrea J Sant
Journal:  J Immunol       Date:  2012-03-30       Impact factor: 5.422

2.  Genetic diversity and C2-like subgenogroup strains of enterovirus 71, Taiwan, 2008.

Authors:  Yuan-Pin Huang; Tsuey-Li Lin; Li-Ching Hsu; Yu-Ju Chen; Yin-Hsin Tseng; Chiu-Chu Hsu; Wen-Bin Fan; Jyh-Yuan Yang; Feng-Yee Chang; Ho-Sheng Wu
Journal:  Virol J       Date:  2010-10-20       Impact factor: 4.099

3.  Immunodominant IgM and IgG Epitopes Recognized by Antibodies Induced in Enterovirus A71-Associated Hand, Foot and Mouth Disease Patients.

Authors:  Kam Leng Aw-Yong; I-Ching Sam; Mia Tuang Koh; Yoke Fun Chan
Journal:  PLoS One       Date:  2016-11-02       Impact factor: 3.240

4.  Dominant CD4-dependent RNA-dependent RNA polymerase-specific T-cell responses in children acutely infected with human enterovirus 71 and healthy adult controls.

Authors:  Shuangsuo Dang; Ning Gao; Yaping Li; Mei Li; Xiufang Wang; Xiaoli Jia; Song Zhai; Xin Zhang; Jingkun Liu; Huiling Deng; Tao Dong
Journal:  Immunology       Date:  2014-05       Impact factor: 7.397

5.  Protection against enterovirus 71 with neutralizing epitope incorporation within adenovirus type 3 hexon.

Authors:  Xingui Tian; Xiaobo Su; Xiao Li; Haitao Li; Ting Li; Zhichao Zhou; Tianhua Zhong; Rong Zhou
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

6.  A dominant EV71-specific CD4+ T cell epitope is highly conserved among human enteroviruses.

Authors:  Ruicheng Wei; Chunfu Yang; Mei Zeng; Frances Terry; Kai Zhu; Chunhui Yang; Ralf Altmeyer; William Martin; Anne S De Groot; Qibin Leng
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

7.  Protection against lethal enterovirus 71 challenge in mice by a recombinant vaccine candidate containing a broadly cross-neutralizing epitope within the VP2 EF loop.

Authors:  Longfa Xu; Delei He; Zhiqun Li; Jun Zheng; Lisheng Yang; Miao Yu; Hai Yu; Yixin Chen; Yuqiong Que; James Wai Kuo Shih; Gang Liu; Jun Zhang; Qinjian Zhao; Tong Cheng; Ningshao Xia
Journal:  Theranostics       Date:  2014-02-18       Impact factor: 11.556

8.  Antigenic and genetic diversity of human enterovirus 71 from 2009 to 2012, Taiwan.

Authors:  Yuan-Pin Huang; Tsuey-Li Lin; Ting-Han Lin; Ho-Sheng Wu
Journal:  PLoS One       Date:  2013-11-15       Impact factor: 3.240

9.  Recombinant tandem multi-linear neutralizing epitopes of human enterovirus 71 elicited protective immunity in mice.

Authors:  Yue-Xiang Li; Hui Zhao; Rui-Yuan Cao; Yong-Qiang Deng; Jian-Feng Han; Shun-Ya Zhu; Jie Ma; Long Liu; E-De Qin; Cheng-Feng Qin
Journal:  Virol J       Date:  2014-05-06       Impact factor: 4.099

10.  Oral immunization with recombinant enterovirus 71 VP1 formulated with chitosan protects mice against lethal challenge.

Authors:  Fushun Zhang; Chunsheng Hao; Shuo Zhang; Aqian Li; Quanfu Zhang; Wei Wu; Lin Liu; Chuan Li; Mifang Liang; Xiuling Li; Dexin Li
Journal:  Virol J       Date:  2014-05-06       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.